Latest filing published 12 Feb 2024 for ImmunoGen, Inc.. Read the official filing
No signal scores available.
Richard John Wallace is a declared insider of ImmunoGen, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 7 November 2023 to 12 February 2024.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 12 February 2024 came the latest disclosure, a transaction in ImmunoGen, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations